Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 4
2012 1
2013 3
2014 1
2015 1
2016 3
2017 6
2018 6
2019 3
2020 11
2021 15
2022 9
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response.
Golebski K, Layhadi JA, Sahiner U, Steveling-Klein EH, Lenormand MM, Li RCY, Bal SM, Heesters BA, Vilà-Nadal G, Hunewald O, Montamat G, He FQ, Ollert M, Fedina O, Lao-Araya M, Vijverberg SJH, Maitland-van der Zee AH, van Drunen CM, Fokkens WJ, Durham SR, Spits H, Shamji MH. Golebski K, et al. Among authors: vijverberg sjh. Immunity. 2021 Feb 9;54(2):291-307.e7. doi: 10.1016/j.immuni.2020.12.013. Epub 2021 Jan 14. Immunity. 2021. PMID: 33450188 Free article. Clinical Trial.
Children and the European Respiratory Society: from silos to synergies.
Gappa M, Bush A, Ersu RH, Soto-Martinez ME, Moeller A, Pijnenburg MW, Singh V, Vijverberg SJH, Zar HJ. Gappa M, et al. Among authors: vijverberg sjh. Eur Respir J. 2023 Nov 9;62(5):2301692. doi: 10.1183/13993003.01692-2023. Print 2023 Nov. Eur Respir J. 2023. PMID: 37945040 No abstract available.
Treating severe asthma: Targeting the IL-5 pathway.
Principe S, Porsbjerg C, Bolm Ditlev S, Kjaersgaard Klein D, Golebski K, Dyhre-Petersen N, van Dijk YE, van Bragt JJMH, Dankelman LLH, Dahlen SE, Brightling CE, Vijverberg SJH, Maitland-van der Zee AH. Principe S, et al. Among authors: vijverberg sjh. Clin Exp Allergy. 2021 Aug;51(8):992-1005. doi: 10.1111/cea.13885. Epub 2021 May 21. Clin Exp Allergy. 2021. PMID: 33887082 Free PMC article. Review.
What do we need to transfer pharmacogenetics findings into the clinic?
Slob EMA, Vijverberg SJH, Pijnenburg MW, Koppelman GH, Maitland-van der Zee AH. Slob EMA, et al. Among authors: vijverberg sjh. Pharmacogenomics. 2018 May;19(7):589-592. doi: 10.2217/pgs-2018-0026. Epub 2018 Apr 27. Pharmacogenomics. 2018. PMID: 29701121 No abstract available.
Precision Medicine in Asthma Therapy.
Principe S, Vijverberg SJH, Abdel-Aziz MI, Scichilone N, Maitland-van der Zee AH. Principe S, et al. Among authors: vijverberg sjh. Handb Exp Pharmacol. 2023;280:85-106. doi: 10.1007/164_2022_598. Handb Exp Pharmacol. 2023. PMID: 35852633
Pharmacogenomics in Pediatric Patients: Towards Personalized Medicine.
Maagdenberg H, Vijverberg SJ, Bierings MB, Carleton BC, Arets HG, de Boer A, Maitland-van der Zee AH. Maagdenberg H, et al. Among authors: vijverberg sj. Paediatr Drugs. 2016 Aug;18(4):251-60. doi: 10.1007/s40272-016-0176-2. Paediatr Drugs. 2016. PMID: 27142473 Free PMC article. Review.
Childhood asthma in the new omics era: challenges and perspectives.
Golebski K, Kabesch M, Melén E, Potočnik U, van Drunen CM, Reinarts S, Maitland-van der Zee AH, Vijverberg SJH; PERMEABLE consortium. Golebski K, et al. Among authors: vijverberg sjh. Curr Opin Allergy Clin Immunol. 2020 Apr;20(2):155-161. doi: 10.1097/ACI.0000000000000626. Curr Opin Allergy Clin Immunol. 2020. PMID: 31985545 Free PMC article. Review.
71 results